American Academy of Neurology: Which Clot-Busting Drug Is Tied to Better Recovery After Stroke?
October 17, 2024
October 17, 2024
MINNEAPOLIS, Minnesota, Oct. 17 (TNSres) -- The American Academy of Neurology issued the following news release on Oct. 16, 2024:
For people with ischemic stroke, treatment with the clot-busting drug tenecteplase is associated with a slightly higher likelihood of an excellent recovery and reduced disability three months later than the drug alteplase, according to a meta-analysis published in the October 16, 2024, online issue of Neurology(R), the medical journal of the American Acad . . .
For people with ischemic stroke, treatment with the clot-busting drug tenecteplase is associated with a slightly higher likelihood of an excellent recovery and reduced disability three months later than the drug alteplase, according to a meta-analysis published in the October 16, 2024, online issue of Neurology(R), the medical journal of the American Acad . . .